Client RetentionVeeva announced Merck, a 6th top-20 pharma, will stay on Veeva CRM, offsetting 2 exits, implying a net positive for Veeva after accounting for licensing fee savings.
Product InnovationThe accelerated platform innovation and product development afforded by owning the underlying infrastructure of the platform will provide sustained runway for cross-selling opportunities and value creation.
Strategic PartnershipsMerck's decision to migrate to Vault CRM builds upon a 10-year strategic partnership, indicating a deepening of their relationship with Veeva.